Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better training help providers spot fetal alcohol spectrum disorders sooner?

NCT ID NCT05960461

Knowledge-focused Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

Researchers at the University of Rochester are testing a program called FMF Connect Pro that trains mental health providers to screen for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders, and support caregivers through a companion app. The study compares two training methods: a 13-session tele-mentoring program and a self-directed online version. About 250 mental health providers across the United States will take part, with assessments at the start and after 6 and 12 months. The goal is to see whether the training changes provider knowledge, confidence, and practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FMF Connect Pro, a provider training program with a caregiver app for fetal alcohol spectrum disorders
What this could lead to
If the training works, more mental health providers could routinely screen for prenatal alcohol exposure and diagnose fetal alcohol spectrum disorders, connecting families to support earlier.
What could go wrong
This study measures how providers learn and change their practice, not whether children improve. Training may not translate into lasting changes in care, and the results may not apply outside the United States.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Licensed mental health provider or supervised trainee * Employed by a community mental agency or in private practice * provides mental health services to children ages 3 to 12 or their families * provides services in the United States * Fluency in English * Access to the internet Exclusion Criteria: * Provides services outside of the United States * Does not provide mental health services to children ages 3 to 12

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal alcohol spectrum disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal alcohol spectrum disorder fetal alcohol syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal alcohol spectrum disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mt. Hope Family Center

    RECRUITING

    Rochester, New York, 14608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.